Video: Intel upbeat on SoCs, recovery
Rick Merritt, EE Times
(05/13/2009 1:02 AM EDT)
SANTA CLARA, Calif. — Intel Corp. plans to offer 3G cellular silicon as part of its move into systems-on-chip for networked devices, said chief executive of Paul Otellini. Separately, the company will not try to offer a 28 nm process technology despite comments some will use that interim node.
"We want to have that [3G] capability," said Otellini in a Q&A session at an annual analysts meeting here. Cellular silicon "could be in a daughter card, but in some platforms it needs to be integrated into the SoC, and we want to be able to do any configuration," he said.
Otellini said he had nothing to announce about how or when Intel would obtain 3G silicon.
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Related News
- Aion Silicon Joins Intel Foundry Accelerator Design Services Alliance to Deliver Next-Generation Custom SoCs at Scale
- Keysight EDA and Intel Foundry Collaborate on EMIB-T Silicon Bridge Technology for Next-Generation AI and Data Center Solutions
- Worldwide Silicon Wafer Shipments and Revenue Start Recovery in Late 2024, SEMI Reports
- Silicon IP Provider, Chips&Media Unveils New Multi Video Codec IP, WAVE6 Gen2+
- DisplayPort Rx PHY and Controller IP Cores in multiple Leading Technology Nodes for Next-Generation Video SoCs
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






